Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record.

Mitochondrial Toxicity Associated with Linezolid

Open access
Soriano, Alex, Miró, Oscar, Mensa, Josep·2005·New England Journal of Medicine

Abstract

To the Editor: Linezolid belongs to a family of antimicrobial agents (oxazolidinones) that inhibit bacterial protein synthesis by preventing the fusion of 30S and 50S ribosomal subunits.1 Hyperlactatemia, metabolic acidosis, and peripheral neuropathy are adverse effects of linezolid,2,3 which could be related to the drug's capacity for interference with mitochondrial function.4 We studied mitochondria from three patients in whom asthenia and hyperlactatemia developed during a prolonged course of oral linezolid (600 mg every 12 hours). Patient 1, a 25-year-old man with Enterococcus faecium infection of a knee prosthesis, received oral linezolid. After three months, mild asthenia and hyperlactatemia developed . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm200511243532123

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 181

Metadata

Authors
Soriano, A., Miró, O., & Mensa, J.
Venue
New England Journal of Medicine
Published
2005-11-24
Volume
353
Issue
21
Pages
2305-2306
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2334114220
Cited by
181
References
0
FWCI
3.00
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mitochondrial Toxicity Associated with Linezolid. https://app.cochat.ai/papers/10.1056/nejm200511243532123
The paper
Soriano, A., Miró, O., & Mensa, J. (2005). Mitochondrial Toxicity Associated with Linezolid. New England Journal of Medicine. https://doi.org/10.1056/nejm200511243532123

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.